Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)NCT05195528PHATPhase 3Completed2022-11-21Actual
Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase InhibitorNCT05198310Kiniksa Pharmaceuticals, Ltd.Phase 2Completed2024-02-08Actual
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialNCT05200936Definium Therapeutics US, Inc.Phase 2Completed2023-11-06Actual
A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry EyeNCT05201170PTNPhase 3Completed2023-09-01Actual
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisNCT05201404Can-Fite BioPharmaPhase 3Recruiting2026-02Estimated
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisNCT05201638Immunic AGPhase 3Active not recruiting2026-11Estimated
A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersNCT05206370Achieve Life SciencesPhase 3Completed2023-03-21Actual
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsNCT05208047COGTPhase 3Recruiting2025-09-30Actual
THIO Sequenced With Cemiplimab in Advanced NSCLCNCT05208944Maia BiotechnologyPhase 2Active not recruiting2027-09-30Estimated
A Phase 3 Study of Rusfertide in Patients With Polycythemia VeraNCT05210790PTGXPhase 3Active not recruiting2025-02-21Actual
Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847AARDPhase 2Completed2023-02-03Actual
ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)NCT05216224ACRSPhase 2Completed2022-12-23Actual
Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)NCT05217667Arrowhead PharmaceuticalsPhase 2Terminated2023-05-02Actual
A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial DiseaseNCT05218655PTC TherapeuticsPhase 3Completed2025-04-15Actual
Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy BodiesNCT05225415Cognition TherapeuticsPhase 2Completed2024-11-25Actual
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsNCT05232916GLSIPhase 3Recruiting2031-12Estimated
Lomecel-B Effects on Alzheimer's DiseaseNCT05233774LGVNPhase 2Completed2023-09-29Actual
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic ConjunctivitisNCT05234554ALDXPhase 3Completed2023-04-22Actual
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerNCT05243550URGNPhase 3Active not recruiting2023-04-26Actual
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt DiseaseNCT05244304BLTEPhase 3Completed2025-08-04Actual
4D-710 in Adult Patients With Cystic FibrosisNCT052482304D Molecular TherapeuticsPhase 2Recruiting2027-06Estimated
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerNCT05257408Corcept TherapeuticsPhase 3Active not recruiting2025-03-31Actual
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)NCT05263999EquilliumPhase 3Terminated2025-04-22Actual
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)NCT05269355PTC TherapeuticsPhase 2, Phase 3Terminated2024-06-17Actual
Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe GastroparesisNCT05270460Processa PharmaceuticalsPhase 2Completed2022-09-29Actual
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 StudyNCT05271370CytoDyn, Inc.Phase 2, Phase 3Terminated2022-06-20Actual
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)NCT05271552BioXcel Therapeutics IncPhase 3Completed2023-04-21Actual
A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNCT05271604BioAtla, Inc.Phase 2Completed2025-09-22Actual
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With FibromyalgiaNCT05273749Tonix Pharmaceuticals, Inc.Phase 3Completed2023-11-14Actual
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung CancerNCT05275673Faeth TherapeuticsPhase 2Terminated2023-01-24Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.